Professional Documents
Culture Documents
Abstract: This work investigates the application of a “Process Analytical Technology” (PAT)
analyser to control the substrate concentration over traditional sequential batch control for an
industrial scale fed-batch penicillin fermentation. A simulation that utilises the historical data
from four batches, where a sequential batch control strategy was implemented, was used as the
benchmark reference for this comparison. The simulation accurately predicts the main outputs
variables of biomass and penicillin, given the inputs from the historical data set. The simulation
includes a PAT analyser, used to build a calibration model with the available off-line substrate
concentration from one of the batches. The prediction from this calibration model was used as
the controlled variable within a proportional integral (PI) controller to manipulate the substrate
feed rate for the three remaining batches. Performance of each control strategy was analysed by
comparing the final penicillin yield of each batch. An increase of 35, 20 and 9% was observed for
the three batches controlled using the PI controller compared with the sequential batch control
strategy.
Nohoperatorh
35
intervention 30
Penicillin yield (g L )
−1
25
Onehsupplier
Improving product yield and maintaining consistent oper- Nohvariationh
Homogeneoushmixture 20
15
Seedhtank
ation is the ultimate goal in batch manufacturing. Achiev- Processh
10
Consanthintialhconditions
5
variability Highhconsistenthyields
difficult, with a major challenge being the ability to design h Equalhbatchhlenght
Real world
a robust control strategy that can handle the large varia- Variableh 40
Final penicillin titre
Rawhmaterials controlh
Substratehtank 35
operatorhintervenation
Penicillin yield (g L−1)
20
Heterogeneoushmixture
raw materials and the initial conditions of the batch. These Seedhtank
15
10
measurements
0 50 100 150 200 250 300
Seasonalhvariationh Batch time (h)
PAT analyser is compared, using a simulation, against the adjusted by the operator to maximise production of peni-
substrate feeding rate of four industrial scale fed-batch cillin while ensuring the dissolved oxygen was kept above
fermentations. The simulation accurately describe the in- its critical value of 4 mg L−1 . The water for injection was
dustrial scale fermentations by comparing the predicted used to reduce the viscosity of the broth and was manually
outputs against those recorded in the batch records using controlled. The air flow and head pressure were controlled
the main process inputs of each industrial batch. by the operator to ensure the dissolved oxygen concen-
tration was kept above its critical value. The discharge
2. MATERIALS AND METHODS rate ensured that the volume of the bioreactor was kept
below its set-point of 100,000 litres. Further details of these
control variables can be found in [5].
The simulation used in this work is a 1st principles
mathematical model of a fed-batch 100,000 litre penicillin 250
fermentation that includes a simulated PAT analyser in Batch 1
Batch 2
the form of a Raman spectroscopy probe. The simulation Batch 3
referenced as “IndPenSim” uses the model developed by 200 Batch 4
Fs S 700
Batch 1
P Batch 2
IndPenSim
Fdischarge V Batch 3
600
Fwater X Batch 4
Water for injection (L hr−1)
Fg DO2 500
Press
X0 t 400
Spectral data
Initial conditions 300
100
6223
19th IFAC World Congress
Cape Town, South Africa. August 24-29, 2014
4
90 x 10
10
80
9.5
70 9
8.5
Aeration rate (L hr )
60
−1
Volume (L)
50
7.5
40
Batch 1
7 Batch 1 (s)
30 Batch 2
6.5
Batch 1 Batch 2 (s)
20 Batch 3
Batch 2 6
Batch 3 (s)
Batch 3
10 5.5 Batch 4
Batch 4
Batch 4 (s)
0 5
0 50 100 150 200 250 300 0 50 100 150 200 250 300
Batch time (hr) Batch time (hr)
Fig. 5. Air flow rate for four industrial batches. Fig. 7. Recorded volume for four industrial batches com-
pared to the simulation volume using IndPenSim
1.4 (·−historical data,−− simulated data).
1.3
40
1.2
Bioreactor head pressure (bar)
35
1.1
30
1
Penicillin yield (g L−1)
25
0.9
20
0.8 Batch 1
Batch 2 Batch 1
0.7 Batch 3 15 Batch 1 (s)
Batch 4 Batch 2
0.6 Batch 2 (s)
10
Batch 3
Batch 3 (s)
0 50 100 150 200 250 5 Batch 4
Batch time (hr) Batch 4 (s)
0
0 50 100 150 200 250 300
Fig. 6. Vessel pressure for four industrial batches. Batch time (hr)
6224
19th IFAC World Congress
Cape Town, South Africa. August 24-29, 2014
6 −7
x 10 x 10
3 12
10
2.5
1
2
0.5
0
0 −2
200 400 600 800 1000 1200 1400 1600 1800 2000 2200 0 500 1000 1500 2000 2500
Wavenumber (cm−1) Wavenumber (cm−1)
Fig. 9. Spectra collected from Batch 1 Fig. 10. Regression coefficients B̂, calculated for the first
. three latent variables of the PLS model for Batch 1.
column vectors of the matrix represent the wavenumbers xl10
−3
6
of the spectra. The wavenumbers of interest that contain Substratelconcentrationl(s)
information related to the substrate concentration were Off−linelsubstratelconcentration
5.5
chosen using the regression coefficients (B) of a PLS model
taking XSpec as the X-block and SOF as the Y block. Substratelconcentrationl(glL−1)
5
The PLS model was built using the technique outlined Validation
in [8]. The spectral data was first decomposed in to its 4.5 data
principal components, generating a matrix of scores, T,
and loadings, P. The off-line substrate concentration was 4
decomposed in a similar fashion generating a matrix of
scores, U, and loadings, Q, as shown below: 3.5
6
proved by exchanging the scores, T and U, in an iterative Substrate concentration (s)
calculation. This allows information from one block to 5.5
Predicted substrate concentrtaion
6225
19th IFAC World Congress
Cape Town, South Africa. August 24-29, 2014
Fs controllerR
Filter −3
x 10
14
PredictedR Batch 2 (Sequential control)
SubstrateRconc Batch 2 (PI control)
SubstrateRtank Batch 3 (Sequential control)
CalibrationR 12
Batch 3 (PI control)
modelRR
Substrate concentration (g L−1)
3. DISCUSSION 4
The mathematical simulation, IndPenSim, was used to 50 100 150 200 250
test the performance of a control strategy using a PAT Batch time (hr)
6226
19th IFAC World Congress
Cape Town, South Africa. August 24-29, 2014
30
rate control of a Vibrio cholerae fed-batch cultivation
25 Journal of Biotechnology 115 (2005) 67-79
[4] Stephen Goldrick, Barry Lennox, David Lovett, Keith
20
Batch 2 (APC)
Smith, Gary Montague The Development of a Simu-
15 Batch 2 (Operator controlled) lation to Address the Real Challenges Associated with
Batch 3 (APC) Industrial Scale Penicillin Production. Computer Ap-
10 Batch 3 (Operator controlled)
Batch 4 (APC)
plications in Biotechnology conference, Mumbai Dec
5 Batch 4 (Operator controlled) 2013
[5] Stephen Goldrick, Andrei Stefan, Gary Montague,
0
0 50 100 150 200 250 300 David Lovett, and Barry Lennox The development
Batch time (hr)
of a simulation to address the pratical challenges
associated with industrial scale penicillin production
Fig. 16. Comparison of penicillin concentrations using the Biotechnology and Bioengineering, manuscript in
APC controller compared to when it is controller by preparation to be submitted in Jan 2014
the operator. [6] G. C. Paul and C. R. Thomas, A structured model
x 10
4 for hypal differentiation and Penicillin Production
10.5
Using Penicillium chrysogenum Biotechnology and
10 Bioengineerng, 51,558-572 1996.
9.5
[7] Volker Tiller, Juliane Meyerhoff, Ditmar Sziele, Karl
Schgerl, Karl-Heinz Bellgardt , Segregated mathe-
Substrate concentration (g L−1)
9
matical model for the fed-batch cultivation of a high-
8.5 producing strain of Penicillium chrysogenum Journal
8 of Biotechnology, 34, 2, 15, 119-131, 1994
[8] Paul Gemperline Pratical Guide to Chemometrics
7.5 Batch 2 (Sequential control)
Batch 2 (PI control)
Taylor & Francis Group, 2006.
7
Batch 3 (Sequential control)
Batch 3 (PI control)
6.5
Batch 4 (Sequential control)
6 Batch 4 (PI control)
5.5
0 50 100 150 200 250 300
Batch time (hr)
ACKNOWLEDGEMENTS
REFERENCES
[1] Boudreau A. and McMillan K., Gregory, New direc-
tions in bioprocess modelling an control: Maximising
process analytical technolology benifits. ISA, 2007
[2] E.K. Read, J.T. Park, R.B. Shah, B.S. Riley, K.A.
Brorson, A.S. Rathore Process Analytical Technol-
ogy (PAT) for Biopharmaceutical Products: Part I.
6227